Cambridge Podiatry Network Pc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 425 Salem St, Medford, MA 02155 Phone: 781-396-8737 Fax: 781-395-8197 |
Dan Seligman, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: Zero Governors Ave, Suite 7, Medford, MA 02155 Phone: 781-391-3900 |
Dan Seligman Podiatrist Medicare: Medicare Enrolled Practice Location: 0 Governors Ave, Suite 7, Medford, MA 02155 Phone: 781-391-3900 |
North Atlantic Podiatry, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 83 Sheridan Ave, Medford, MA 02155 Phone: 978-458-4011 Fax: 978-458-4020 |
John L Sherman, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5255 Fax: 781-306-5487 |
Jack E Luber, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 425 Salem St, Medford, MA 02155 Phone: 781-933-3734 |
Dr. Joseph Robert Murano, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, 207, Medford, MA 02155 Phone: 781-396-0120 Fax: 781-395-4535 |
Raymond S. Murano Dpm Pc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 101 Main St, Suite 207, Medford, MA 02155 Phone: 781-396-0120 |
Dr. Raymond S. Murano, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Ste 207, Medford, MA 02155 Phone: 781-396-0120 Fax: 781-395-4535 |
News Archive
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
For twenty years, it has been understood that dystrophin is expressed in differentiated muscle fibers where it is part of a protein complex that crosses the membrane and connects the extracellular matrix to the actin network inside the cell to provide structural integrity.
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
A team of scientists at Karolinska Institutet and Harvard University has taken a major step towards treatment for heart attack, by instructing the injured heart in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.
Ipsen today announced that the scientific journal Pediatrics published the detailed results of the phase III randomized study showing both the efficacy and the safety of Dysport in the treatment of dynamic equinus foot deformity, a condition associated with cerebral palsy in children.
› Verified 3 days ago